{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T02:51:03Z","timestamp":1775703063612,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2305204, 2023YFC2307301"],"award-info":[{"award-number":["2022YFC2305204, 2023YFC2307301"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Microbiol Biotechnol"],"DOI":"10.1007\/s11274-026-04858-5","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T10:19:35Z","timestamp":1772792375000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Simultaneous detection of Mycobacterium tuberculosis complex and rifampin\/isoniazid resistance with sanity 2.0 MTBC-MDR: a moderate-complexity automated NAAT"],"prefix":"10.1007","volume":"42","author":[{"given":"Xichao","family":"Ou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xundi","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongfang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenzhi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feina","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yajie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruida","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanlin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiwen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"key":"4858_CR9","doi-asserted-by":"crossref","unstructured":"Chakravorty S, Simmons AM, Rowneki M, Parmar H, Cao Y, Ryan J et al (2017) The new Xpert MTB\/RIF ultra: improving detection of and resistance to rifampin in an assay suitable for Point-of-Care testing. Mbio 8:e00812-17","DOI":"10.1128\/mBio.00812-17"},{"key":"4858_CR11","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.jinf.2012.02.012","volume":"64","author":"K Chang","year":"2012","unstructured":"Chang K, Lu W, Wang J et al (2012) Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB\/RIF assay: a meta-analysis. J Infect 64:580\u2013588","journal-title":"J Infect"},{"key":"4858_CR17","volume-title":"Performance standards for susceptibility testing of Mycobacteria, nocardia spp., and other aerobic actinomycetes","author":"CLSI","year":"2023","unstructured":"CLSI (2023) Performance standards for susceptibility testing of mycobacteria, nocardia spp., and other aerobic actinomycetes. 2nd edition. CLSI supplement M24S. Clinical and Laboratory Standards Institute"},{"key":"4858_CR25","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41579-024-01025-1","volume":"22","author":"M Farhat","year":"2024","unstructured":"Farhat M, Cox H, Ghanem M, Denkinger CM, Rodrigues C, Abd El Aziz SM et al (2024) Drug-resistant tuberculosis: a persistent global health concern. Nat Rev Microbiol 22:617\u2013635","journal-title":"Nat Rev Microbiol"},{"key":"4858_CR13","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S1473-3099(16)30407-8","volume":"17","author":"M Gegia","year":"2017","unstructured":"Gegia M, Winters N, Benedetti A, van Soolingen D, Menzies D (2017) Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysis. Lancet Infect Dis 17:223\u2013234","journal-title":"Lancet Infect Dis"},{"key":"4858_CR16","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1128\/JCM.01463-09","volume":"48","author":"D Helb","year":"2010","unstructured":"Helb D, Jones M, Story E, Boehme C, Wallace E, Ho K et al (2010) Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of On-Demand, Near-Patient technology. J Clin Microbiol 48:229\u2013237","journal-title":"J Clin Microbiol"},{"key":"4858_CR12","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.2217\/fmb.11.84","volume":"6","author":"SD Lawn","year":"2011","unstructured":"Lawn SD, Nicol MP (2011) Xpert\u00ae MTB\/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance. Future Microbiol 6:1067\u20131082","journal-title":"Future Microbiol"},{"key":"4858_CR23","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1016\/j.cmi.2021.09.014","volume":"28","author":"D Liu","year":"2022","unstructured":"Liu D, Huang F, Zhang G, He W, Ou X, He P et al (2022) Whole-Genome sequencing for surveillance of tuberculosis drug resistance and determination of resistance level in China. Clin Microbiol Infect 28:e9\u2013731e15","journal-title":"Clin Microbiol Infect"},{"key":"4858_CR15","doi-asserted-by":"publisher","first-page":"100129","DOI":"10.1016\/j.imj.2024.100129","volume":"3","author":"D Liu","year":"2024","unstructured":"Liu D, Zhao B, Zheng Y, Ou X, Wang S et al (2024) Characterization of isoniazid resistance and genetic mutations in Isoniazid-resistant and rifampicin-susceptible Mycobacterium tuberculosis in China. Infect Med 3:100129","journal-title":"Infect Med"},{"key":"4858_CR4","doi-asserted-by":"crossref","unstructured":"MacLean E, Kohli M, Weber SF, Suresh A, Schumacher SG, Denkinger CM et al (2020) Advances in molecular diagnosis of tuberculosis. J Clin Microbiol 58:e01582\u201319","DOI":"10.1128\/JCM.01582-19"},{"key":"4858_CR14","doi-asserted-by":"publisher","first-page":"e1000150","DOI":"10.1371\/journal.pmed.1000150","volume":"6","author":"D Menzies","year":"2009","unstructured":"Menzies D, Benedetti A, Paydar A, Royce S, Madhukar P, Burman W et al (2009) Standardized treatment of active tuberculosis in patients with previous treatment and\/or with mono-resistance to isoniazid: a systematic review and meta-analysis. PLoS Med 6:e1000150","journal-title":"PLoS Med"},{"key":"4858_CR10","doi-asserted-by":"crossref","unstructured":"Nathavitharana RR, Cudahy PGT, Schumacher SG, Steingart KR, Pai M, Denkinger CM et al (2017) Accuracy of line probe assays for the diagnosis of pulmonary and multidrug-resistant tuberculosis: a systematic review and meta-analysis. Eur Respir J 49:1601075","DOI":"10.1183\/13993003.01075-2016"},{"key":"4858_CR24","doi-asserted-by":"publisher","first-page":"100899","DOI":"10.1016\/S2666-5247(24)00131-9","volume":"5","author":"S Pei","year":"2024","unstructured":"Pei S, Song Z, Yang W, He W, Ou X, Zhao B et al (2024) The catalogue of mycobacterium tuberculosis mutations associated with drug resistance to 12 drugs in China from a nationwide survey: a genomic analysis. Lancet Microbe 5:100899","journal-title":"Lancet Microbe"},{"key":"4858_CR5","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1093\/infdis\/jiz258","volume":"220","author":"SG Schumacher","year":"2019","unstructured":"Schumacher SG, Wells WA, Nicol MP, Steingart KR, Theron G, Dorman SE et al (2019) Guidance for studies evaluating the accuracy of Sputum-Based tests to diagnose tuberculosis. J Infect Dis 220:S99\u2013S107","journal-title":"J Infect Dis"},{"key":"4858_CR26","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1080\/22221751.2020.1785334","volume":"9","author":"S Swain","year":"2020","unstructured":"Swain S, Sharma D, Hussain T, Pati S (2020) Molecular mechanisms of underlying genetic factors and associated mutations for drug resistance in Mycobacterium tuberculosis. Emerg Microbes Infect 9:1651\u20131663","journal-title":"Emerg Microbes Infect"},{"key":"4858_CR8","volume-title":"Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB","author":"World Health Organization","year":"2013","unstructured":"World Health Organization (2013) Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB. World Health Organization, Geneva"},{"key":"4858_CR3","unstructured":"World Health Organization (2015) WHO End TB Strategy. Geneva: World Health Organization"},{"key":"4858_CR6","volume-title":"Technical manual for drug susceptibility testing of medicines used in the treatment of tuberculosis","author":"World Health Organization","year":"2018","unstructured":"World Health Organization (2018) Technical manual for drug susceptibility testing of medicines used in the treatment of tuberculosis. World Health Organization, Geneva"},{"key":"4858_CR20","volume-title":"Molecular assays intended as initial tests for the diagnosis of pulmonary and extrapulmonary TB and rifampicin resistance in adults and children: rapid communication. Policy update","author":"World Health Organization","year":"2020","unstructured":"World Health Organization (2020) Molecular assays intended as initial tests for the diagnosis of pulmonary and extrapulmonary TB and rifampicin resistance in adults and children: rapid communication. Policy update. World Health Organization, Geneva"},{"key":"4858_CR7","volume-title":"WHO consolidated guidelines on tuberculosis. Module 3: diagnosis - rapid diagnostics for tuberculosis detection, 2021 update","author":"World Health Organization","year":"2021","unstructured":"World Health Organization (2021a) WHO consolidated guidelines on tuberculosis. Module 3: diagnosis - rapid diagnostics for tuberculosis detection, 2021 update. World Health Organization, Geneva"},{"key":"4858_CR21","volume-title":"WHO operational handbook on tuberculosis. Module 3: diagnosis-rapid diagnostics for tuberculosis detention, 2021 update","author":"World Health Organization","year":"2021","unstructured":"World Health Organization (2021b) WHO operational handbook on tuberculosis. Module 3: diagnosis-rapid diagnostics for tuberculosis detention, 2021 update. World Health Organization, Geneva"},{"key":"4858_CR2","volume-title":"Global tuberculosis report 2023","author":"World Health Organization","year":"2023","unstructured":"World Health Organization (2023a) Global tuberculosis report 2023. World Health Organization, Geneva"},{"key":"4858_CR22","volume-title":"Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance, second edition","author":"World Health Organization","year":"2023","unstructured":"World Health Organization (2023b) Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance, second edition. World Health Organization, Geneva"},{"key":"4858_CR1","doi-asserted-by":"publisher","DOI":"10.54394\/CJQU6666","volume-title":"Global tuberculosis report 2024","author":"World Health Organization","year":"2024","unstructured":"World Health Organization (2024a) Global tuberculosis report 2024. World Health Organization, Geneva"},{"key":"4858_CR19","doi-asserted-by":"publisher","DOI":"10.2471\/B09111","volume-title":"Target product profiles for tuberculosis diagnosis and detection of drug resistance","author":"World Health Organization","year":"2024","unstructured":"World Health Organization (2024b) Target product profiles for tuberculosis diagnosis and detection of drug resistance. World Health Organization, Geneva"}],"container-title":["World Journal of Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11274-026-04858-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11274-026-04858-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11274-026-04858-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T02:04:16Z","timestamp":1775700256000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11274-026-04858-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":25,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["4858"],"URL":"https:\/\/doi.org\/10.1007\/s11274-026-04858-5","relation":{},"ISSN":["1573-0972"],"issn-type":[{"value":"1573-0972","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"assertion":[{"value":"12 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interest"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of Anhui chest hospital (K2022-022).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional Review Board Statement"}}],"article-number":"119"}}